Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

13.08
Delayed Data
As of 4:00pm ET
 -0.76 / -5.49%
Today’s Change
10.85
Today|||52-Week Range
38.89
-63.92%
Year-to-Date
Biotech Stocks to Watch: Part 1
1:04pm / TheStreet.com - Paid Partner Content
Recommended Reading: Teva
Nov 13 / TheStreet.com - Paid Partner Content
Arthur Zaske & Associates, LLC Buys Vanguard Energy, Teva Pharmaceutical Industries, ...
Nov 16 / GuruFocus News - Paid Partner Content
BioDelivery (BDSI) Q3 Earnings, Sales Beat Estimates
Nov 10 / Zacks.com - Paid Partner Content
Hampstead Capital LLP Buys Merck Inc, American International Group Inc, Pioneer Natur...
Nov 16 / GuruFocus News - Paid Partner Content
VIVUS (VVUS) Q3 Loss Narrows, Qsymia Falters, Shares Down
Nov 09 / Zacks.com - Paid Partner Content
AstraZeneca's (AZN) Asthma Drug Benralizumab Approved by FDA
Nov 15 / Zacks.com - Paid Partner Content
Mylan (MYL) Misses on Earnings and Sales Estimates in Q3
Nov 06 / Zacks.com - Paid Partner Content
Orexigen (OREX) Q3 Loss Narrower Than Expected, Stock Up
Nov 14 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Pfizer, Teva's Q3 Earnings, Novartis Seeks New Indication for K...
Nov 06 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close13.84
Today’s open13.82
Day’s range12.97 - 13.84
Volume236,653
Average volume (3 months)24,906,531
Market cap$14.0B
Dividend yield6.50%
Data as of 4:00pm ET, 11/20/2017

Growth & Valuation

Earnings growth (last year)-96.18%
Earnings growth (this year)-25.81%
Earnings growth (next 5 years)-0.30%
Revenue growth (last year)+12.01%
P/E ratioNM
Price/Sales1.59
Price/Book0.47

Competitors

 Today’s
change
Today’s
% change
BGNEBeiGene Ltd+0.69+0.82%
TYMETyme Technologies In...-0.01-0.25%
OASMOasmia Pharmaceutica...0.000.00%
Data as of 4:00pm ET, 11/20/2017

Financials

Next reporting dateFebruary 8, 2018
EPS forecast (this quarter)$0.83
Annual revenue (last year)$22.0B
Annual profit (last year)$330.0M
Net profit margin1.50%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Kåre Schultz
President &
CEO-Global Operations
Carlo de Notaristefani
Corporate headquarters
Petach Tikva, Hamerkaz

Forecasts